3/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
3/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
批准号:
8758044
负责人:
ROBERT W BUCHANAN
金额:
$34.54万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-16 至 2019-04-30
关键词:
Amygdaloid structureBehaviorBiological MarkersBrainCognitiveDataDiseaseDissociationEmotionsExhibitsFaceFosteringFunctional Magnetic Resonance ImagingFunctional disorderGoalsGoldHospitalsImage AnalysisImpaired cognitionImpairmentIndividualKnowledgeLeadLeast-Squares AnalysisMajor Mental IllnessMapsMarylandMeasuresMental disordersMindModelingMorphologyNeurobiologyNeurocognitionNeurosciences ResearchNormal RangeOutcomeParietalParticipantPathway AnalysisPerformancePrincipal InvestigatorProceduresProcessProcess AssessmentPsychopathologyQuality of lifeRecovery of FunctionRecruitment ActivityRelapseReportingResearchResearch Domain CriteriaResearch PersonnelResourcesRestSamplingSchizoaffective DisordersSchizophreniaSchizophreniform DisorderSiteSocial FunctioningStructureTechniquesTherapeuticThickUniversitiesbasebehavior measurementbrain behaviordesignemerging adultfunctional disabilityfunctional outcomesgray matterimprovedinnovationinterestmirror neuronneural circuitneuroimagingnew therapeutic targetpatient populationpublic health relevancesimulationsocialsocial neurosciencestatisticstheorieswhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Among the major mental illnesses of early adulthood, people with schizophrenia spectrum disorders (SSDs) (i.e., schizophrenia, schizoaffective disorder, schizophreniform disorder) exhibit a continuum of impairment in social functioning. Treatment is minimally effective, and impairments tend to persist. Knowledge on the neurobiology of social cognitive (SCog) process impairment will foster therapeutic discovery. At each of our sites, pilot data show that people with SSDs who are among the most socially impaired have a low likelihood of functional recovery and manifest impairment in discrete brain circuits that are known to be involved in the neurobiology of SCog processes in healthy individuals. Leveraging our pilot data, which is consistent across three sites, and the expertise of our group in SSD research related to phenomenology, outcomes, multi-site neuroimaging, and treatment innovation, we propose to use the Research Domain Criteria (RDoC) investigational framework in people with SSDs to comprehensively and definitively delineate the neurobiology of SCog process impairment. Our approach will employ advanced structural and functional neuroimaging approaches to identify the neural circuitry (along a continuum from healthy controls to people with SSDs) that predict impairments in SCog processes and concomitant social function. We plan to use advanced neuroimaging and network analysis approaches including: 1) gray matter morphology approaches to map the thickness of the cortex and examine cortical thickness network topology, 2) DTI acquisition and analytic approaches to map white matter circuits in the brain; and 3) fMRI-based approaches to engage these same circuits, including functional connectivity measures to obtain detailed measures of circuit function. We will then use our group's expertise in sophisticated multivariate neuroimaging statistics (partial least squares), to extract dimensional features relating brain structure ->brai function -> behavior and provide a comprehensive understanding of the neurobiology of social processes from circuit to behavior across normal and abnormal (SSDs) domains. Our proposal is modeled directly within the RDoC framework; specifically, we are using a Matrix of Analysis as our guiding structure to identify the neurobiology of SCog process constructs from normal controls across the entire schizophrenia spectrum. We anticipate identifying substantially abnormal brain-behavior relationships starting from the level of circuit characterization. The ultimate goal of our collaborative team is to identify new therapeutic targets for the treatment of
social impairments by identifying the underlying neural circuitry and pathophysiology of impaired social function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prebiotic Treatment in People with Schizophrenia
-
批准号:10677261
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2022
-
负责人:ROBERT W BUCHANAN
-
依托单位:
Prebiotic Treatment in People with Schizophrenia
-
批准号:10704720
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2022
-
负责人:ROBERT W BUCHANAN
-
依托单位:
Neuromodulation of Social Cognitive Circuitry in People with Schizophrenia Spectrum Disorders
-
批准号:10580135
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2020
-
负责人:ROBERT W BUCHANAN
-
依托单位:
Prebiotic Treatment in People with Schizophrenia
-
批准号:10448075
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2018
-
负责人:ROBERT W BUCHANAN
-
依托单位:
3/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
-
批准号:9251912
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2014
-
负责人:ROBERT W BUCHANAN
-
依托单位:
3/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
-
批准号:8893157
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2014
-
负责人:ROBERT W BUCHANAN
-
依托单位:
The Effects of Kynurenine Aminotransferase Inhibition in People with Schizophrenia
-
批准号:10425364
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2014
-
负责人:ROBERT W BUCHANAN
-
依托单位:
The Effects of Kynurenine Aminotransferase Inhibition in People with Schizophrenia
-
批准号:10218012
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2014
-
负责人:ROBERT W BUCHANAN
-
依托单位:
The Effects of Kynurenine Aminotransferase Inhibition in People with Schizophrenia
-
批准号:10661742
-
项目类别:
-
资助金额:$88.86万
-
财政年份:2014
-
负责人:ROBERT W BUCHANAN
-
依托单位:
The Effects of Kynurenine Aminotransferase Inhibition in People with Schizophrenia
-
批准号:10016398
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2014
-
负责人:ROBERT W BUCHANAN
-
依托单位:
1/2-Combined Oxytocin and CBSST for Social Function in People with Schizophrenia
-
批准号:8686961
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2013
-
负责人:ROBERT W BUCHANAN
-
依托单位:
1/2-Combined Oxytocin and CBSST for Social Function in People with Schizophrenia
-
批准号:8489498
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2013
-
负责人:ROBERT W BUCHANAN
-
依托单位:
Tretment of negative symptoms and cognitive impairment in schizoprenia
-
批准号:8080313
-
项目类别:
-
资助金额:$50.19万
-
财政年份:2010
-
负责人:ROBERT W BUCHANAN
-
依托单位:
CLINICAL TRIAL: ADJUNCTIVE RISPERIDONE IN CLOZAPINE TREATED PATIENTS
-
批准号:7951146
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2009
-
负责人:ROBERT W BUCHANAN
-
依托单位:
ACISIR: Enhancing Recovery of People with Schizophrenia
-
批准号:8255609
-
项目类别:
-
资助金额:$48.18万
-
财政年份:2008
-
负责人:ROBERT W BUCHANAN
-
依托单位:
ACISIR: Enhancing Recovery of People with Schizophrenia
-
批准号:7439867
-
项目类别:
-
资助金额:$49.01万
-
财政年份:2008
-
负责人:ROBERT W BUCHANAN
-
依托单位:
Tretment of negative symptoms and cognitive impairment in schizoprenia
-
批准号:7483507
-
项目类别:
-
资助金额:$54.44万
-
财政年份:2008
-
负责人:ROBERT W BUCHANAN
-
依托单位:
ACISIR: Enhancing Recovery of People with Schizophrenia
-
批准号:8065936
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2008
-
负责人:ROBERT W BUCHANAN
-
依托单位:
ACISIR: Enhancing Recovery of People with Schizophrenia
-
批准号:7808065
-
项目类别:
-
资助金额:$48.69万
-
财政年份:2008
-
负责人:ROBERT W BUCHANAN
-
依托单位:
CORE--RESEARCH NETWORK DEVELOPMENT CORE
-
批准号:7553492
-
项目类别:
-
资助金额:$51.59万
-
财政年份:2007
-
负责人:ROBERT W BUCHANAN
-
依托单位:
国内基金
海外基金
greenwashing behavior in China:Basedon an integrated view of reconfiguration of environmental authority and decoupling logic
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:YU BYUNGJUN
-
依托单位:
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:YU BYUNGJUN
-
依托单位: